New York Times reports on price cuts for HPV vaccine

Sabin's picture Submitted by Sabin on

Thanks to Pap tests, fatal cervical cancers are almost unknown today in rich countries. But the disease kills an estimated 275,000 women a year in poor countries where Pap tests are impractical and the vaccine is far too expensive for the average woman to afford, so the price cut could lead to a significant advance in women’s health.

II Vaccinology Course for Latin America

11.26.12
Lima, Peru
View event +

Vaccine Information Session

10.24.12
São Paulo, Brazil
View event +

HPV Burden in Latin America

Cervical cancer is one of the leading causes of cancer-related deaths among women in Latin America and the Caribbean. Of the 80,000 new cases and 36,000 cervical cancer deaths reported in the Americas each year, Latin American and Caribbean countries account for the vast majority.

In January 2007, Sabin joined forces with the Pan American Health Organization (PAHO) and the U.S. Centers for Disease Control and Prevention (CDC) to conduct a comprehensive study of HPV epidemiological data in Latin America, in an attempt to address this alarming global health concern.

Price is the Main Barrier to Wider Use of Papillomavirus Vaccine

Sabin's picture Submitted by Sabin on

At its debut 2 years ago, a vaccine that pre-vents cervical cancer was heralded as a public health breakthrough that could poten-tially save millions of women’s lives. Yet although the vaccine is now given routinely to young girls in the United States and Europe, it hasn’t been deployed in poorer countries, where it could make a bigger difference.

Subscribe to RSS - Human Papillomavirus (HPV)